Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GlucoTab with Insulin Degludec and Aspart in Hospitalized T2DM Patients
NCT03387787Phase 3Completed
- Sponsor
- Insel Gruppe
- Start
- Jan 2018
- Primary completion
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin degludec in type 2 diabetes mellitus (T2DM), sponsored by Insel Gruppe. Started Jan 2018; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03387787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03387787.